Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.

Once-daily aminoglycoside (ODA) regimens have been instituted to maximize bacterial killing by optimizing the peak concentration/MIC ratio and to reduce the potential for toxicity. We initiated an ODA program at our institution that utilizes a fixed 7-mg/kg intravenous dose with a drug administratio...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Nicolau, D P, Freeman, C D, Belliveau, P P, Nightingale, C H, Ross, J W, Quintiliani, R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162599/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793867/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.650
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!